Search Grant Opportunities

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

ID: PAR-21-163 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: March 11, 2021, 12:00 a.m. EST
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.
Posted: March 11, 2021, 12:00 a.m. EST
Posted: March 4, 2021, 12:00 a.m. EST
Posted: March 4, 2021, 12:00 a.m. EST
Show All

Overview

Agency
National Institutes of Health (NIH) [HHS]
Category of Funding
Education
Health
Income Security and Social Services
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
93.121 - Oral Diseases and Disorders Research
93.213 - Research and Training in Complementary and Integrative Health
93.242 - Mental Health Research Grants
93.273 - Alcohol Research Programs
93.279 - Drug Abuse and Addiction Research Programs
93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health
93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders
93.865 - Child Health and Human Development Extramural Research
93.866 - Aging Research
93.867 - Vision Research
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 3/11/21 the National Institutes of Health posted grant opportunity PAR-21-163 for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional). The grant will be issued under grant program 93.121 Oral Diseases and Disorders Research.

Timing

Posted Date
March 11, 2021, 12:00 a.m. EST
Closing Date
Aug. 19, 2024, 12:00 a.m. EDT Past Due
Last Updated
June 14, 2024, 3:13 p.m. EDT
Version
2
Archive Date
Sept. 18, 2024

Eligibility

Eligible Applicants
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
County governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Contacts

Contact
National Institutes of Health
Contact Email
fbowebmaster@od.nih.gov
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 402-2541
Additional Information Site
http://grants.nih.gov/grants/guide/pa-files/PAR-21-163.html

Documents

Posted documents for PAR-21-163

Grant Awards

Grants awarded through PAR-21-163

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to PAR-21-163